益生菌对炎症性肠病的治疗作用分析

Analysis of the effect of probiotics on the treatment of inflammatory bowel disease Shandong

目的:观察益生菌治疗炎症性肠病的临床效果。方法:选取本院160例炎症性肠病患者,将患者随机分为治疗组和对照组。对对照组患者进行单纯柳氮磺胺吡啶片治疗,对治疗组患者使用柳氮磺胺吡啶片联合益生菌治疗,对比治疗效果。结果:治疗组有效率达到92.5%,出现并发症1例;对照组有效率仅为75.0%,出现并发症4例。治疗组治疗效果明显好于对照组(P<0.05),两组差异具有统计学意义。结论:益生菌可以明显提升炎症性肠病治疗效果,改善临床控制有效率,值得临床推广。

Objective：To explore the clinical effect of probiotics in the treatment of inflammatory bowel disease. Methods： 160 cases of patients with inflammatory bowel disease were selected, the patients were randomly divided into treatment group and .control group. The controls were only sulfasalazine in the treatment group, the patients in treatment group using sulfasalazine tablets combined with probiotics therapy, comparied the treatment effect. Results：The effective rate of treatment group reached 92.5%, complications occurred in 1 cases; the efficiency of the control group was 75%, complications occurred in 4 cases. Patients in the treatment group curative effect is better than control group （P〈0.05）, with significant difference between the two groups. Conclusion： Probiotics can significantly improve the treatment of inflammatory bowel disease index, improve the clinical efficiency of control, is worth the clinical promotion and application.